首页 > 最新文献

Journal of vascular and interventional neurology最新文献

英文 中文
Balloon Angioplasty for Intracranial Atherosclerotic Disease: A Multicenter Study. 颅内动脉粥样硬化疾病球囊成形术:一项多中心研究。
Lakshmi Sudha Prasanna Karanam, Mukesh Sharma, Anand Alurkar, Sridhar Reddy Baddam, Vijaya Pamidimukkala, Raghavasarma Polavarapu

Aim: To evaluate the role and efficacy of the balloon angioplasty in intracranial atherosclerotic disease (ICAD) in patients who presented with acute stroke due to vessel occlusion and in patients with symptomatic disease despite optimum medical management.

Methods: From 2013 to 2016, a total of 39 patients (24 males and 15 females with a mean age of 64.5 years) underwent balloon angioplasty over a period of 2 years and 8 months in three different institutions in India. Maverick balloon catheter (Boston scientific) is used in all the patients. MRI brain with MR angiogram was done in all the patients prior to intervention. Twenty-three patients who had underlying severe ICAD presented with acute stroke due to vessel occlusion. Sixteen patients presented with symptomatic ICAD with recurrent ischemic attack due to the progressing underlying disease despite optimum medical management. Technical success, peri-procedural events, and clinical outcomes were documented for all the patients.

Results: Technical success (residual stenosis < 50%) was achieved in 37 cases. Extra cranial carotid stenting was required in 2 patients. In patients with acute stroke presentation (NIHSS score median of 16.5), adjuvant intravenous and intra-arterial tissue plasminogen activator were given in 8 and 3 patients, respectively, and mechanical thrombectomy (MT) with solitaire was used in 15 patients. Patients who underwent MT in acute stroke without ICAD were not included in the study. Reocclusion occurred in one patient who developed disabling stroke and one patient died of intra-cerebral hemorrhage. Thus, the mortality of this study is 2%. Clinical outcome was assessed based on mRS. One-month, three-month, and six-month follow-up was available in >90% of the patients. MR angiogram on follow-up of nine months was done in 26 patients, and none of them had restenosis.

Conclusion: Balloon angioplasty is a safe option and can be effectively used in patients of ICAD with acceptable risks and promising outcomes.

目的:评价球囊血管成形术在颅内动脉粥样硬化性疾病(ICAD)患者中因血管闭塞而出现急性脑卒中的患者和有症状的疾病患者的作用和疗效。方法:2013年至2016年,共有39例患者(男性24例,女性15例,平均年龄64.5岁)在印度三家不同的机构接受了2年8个月的球囊血管成形术。所有患者均采用Maverick球囊导管(波士顿科学公司)。所有患者在干预前均行MRI脑及MR血管造影检查。23例潜在的严重ICAD患者因血管闭塞而出现急性卒中。16例患者表现为症状性ICAD伴复发性缺血性发作,尽管有最佳的医疗管理,但由于基础疾病的进展。记录了所有患者的技术成功、术中事件和临床结果。结果:37例手术成功(残余狭窄< 50%)。2例患者行颅外颈动脉支架置入术。急性脑卒中患者(NIHSS评分中位数为16.5),分别给予8例和3例辅助静脉注射和动脉内组织型纤溶酶原激活剂,15例采用机械取栓(MT)联合纸牌。没有ICAD的急性卒中患者接受MT未纳入研究。1例患者发生致残性中风,1例患者死于脑出血。因此,本研究的死亡率为2%。临床结果以mrs为基础进行评估,>90%的患者进行了1个月、3个月和6个月的随访。26例患者随访9个月,均行磁共振血管造影,无一例再狭窄。结论:球囊血管成形术是一种安全的选择,可有效地用于ICAD患者,风险可接受,预后良好。
{"title":"Balloon Angioplasty for Intracranial Atherosclerotic Disease: A Multicenter Study.","authors":"Lakshmi Sudha Prasanna Karanam,&nbsp;Mukesh Sharma,&nbsp;Anand Alurkar,&nbsp;Sridhar Reddy Baddam,&nbsp;Vijaya Pamidimukkala,&nbsp;Raghavasarma Polavarapu","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Aim: </strong>To evaluate the role and efficacy of the balloon angioplasty in intracranial atherosclerotic disease (ICAD) in patients who presented with acute stroke due to vessel occlusion and in patients with symptomatic disease despite optimum medical management.</p><p><strong>Methods: </strong>From 2013 to 2016, a total of 39 patients (24 males and 15 females with a mean age of 64.5 years) underwent balloon angioplasty over a period of 2 years and 8 months in three different institutions in India. Maverick balloon catheter (Boston scientific) is used in all the patients. MRI brain with MR angiogram was done in all the patients prior to intervention. Twenty-three patients who had underlying severe ICAD presented with acute stroke due to vessel occlusion. Sixteen patients presented with symptomatic ICAD with recurrent ischemic attack due to the progressing underlying disease despite optimum medical management. Technical success, peri-procedural events, and clinical outcomes were documented for all the patients.</p><p><strong>Results: </strong>Technical success (residual stenosis < 50%) was achieved in 37 cases. Extra cranial carotid stenting was required in 2 patients. In patients with acute stroke presentation (NIHSS score median of 16.5), adjuvant intravenous and intra-arterial tissue plasminogen activator were given in 8 and 3 patients, respectively, and mechanical thrombectomy (MT) with solitaire was used in 15 patients. Patients who underwent MT in acute stroke without ICAD were not included in the study. Reocclusion occurred in one patient who developed disabling stroke and one patient died of intra-cerebral hemorrhage. Thus, the mortality of this study is 2%. Clinical outcome was assessed based on mRS. One-month, three-month, and six-month follow-up was available in >90% of the patients. MR angiogram on follow-up of nine months was done in 26 patients, and none of them had restenosis.</p><p><strong>Conclusion: </strong>Balloon angioplasty is a safe option and can be effectively used in patients of ICAD with acceptable risks and promising outcomes.</p>","PeriodicalId":88555,"journal":{"name":"Journal of vascular and interventional neurology","volume":"9 4","pages":"29-34"},"PeriodicalIF":0.0,"publicationDate":"2017-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5501126/pdf/jvin-9-4-6.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35164118","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Population-Based Study of the Incidence of Acute Spinal Cord Infarction. 急性脊髓梗死发生率的人群研究。
Adnan I Qureshi, Mohammad Rauf Afzal, M Fareed K Suri

Background: There is a paucity of reliable data regarding incidence of acute spinal cord infarction in population-based studies.

Objectives: To determine the incidence of acute spinal cord infarction using a population-based design.

Methods: Medical records and neuroimaging data of all patients with acute spinal cord infarction from Stearns and Benton Counties, Minnesota, between January 1, 2010 and May 31, 2014 were reviewed. Patients with a first-time diagnosis of spinal cord infarction were categorized as primary or secondary depending upon underlying etiology identified. We calculated the incidences of primary and secondary spinal cord infarction adjusted for age and sex based on the 2010 US census (189,093 resident populations).

Results: The age- and sex-adjusted incidence of spinal cord infarction was 3.1 [95% confidence interval (CI) 1.6-7.2] per100,000 person-years. The age- and sex-adjusted incidence of primary and secondary spinal cord infarction was 1.5 [95% CI 0.6-3.6] and 1.6 [95% CI 0.6-3.6] per 100,000 person-years, respectively. The age-adjusted incidences among men and women were 1.5 [95%CI 0.6-3.7] and 4.6 [95% CI 2.2-8.7] per 100,000 person-years, respectively. No case fatality was observed at one month.

Conclusion: We provide incidence rates for acute spinal cord infarction to assist in future studies and resource allocation.

背景:在以人群为基础的研究中,缺乏关于急性脊髓梗死发生率的可靠数据。目的:采用基于人群的设计确定急性脊髓梗死的发生率。方法:回顾2010年1月1日至2014年5月31日明尼苏达州Stearns和Benton县所有急性脊髓梗死患者的医疗记录和神经影像学资料。首次诊断为脊髓梗死的患者根据确定的潜在病因分为原发性或继发性。我们根据2010年美国人口普查(189,093名常住人口)计算了经年龄和性别调整的原发性和继发性脊髓梗死的发生率。结果:经年龄和性别调整后的脊髓梗死发生率为3.1 / 100000人年[95%可信区间(CI) 1.6-7.2]。经年龄和性别调整后的原发性和继发性脊髓梗死发生率分别为每10万人年1.5例[95% CI 0.6-3.6]和1.6例[95% CI 0.6-3.6]。男性和女性的年龄调整发病率分别为每10万人年1.5例[95%CI 0.6-3.7]和4.6例[95%CI 2.2-8.7]。1个月时未发现死亡病例。结论:我们提供急性脊髓梗死的发生率,以协助未来的研究和资源分配。
{"title":"A Population-Based Study of the Incidence of Acute Spinal Cord Infarction.","authors":"Adnan I Qureshi,&nbsp;Mohammad Rauf Afzal,&nbsp;M Fareed K Suri","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>There is a paucity of reliable data regarding incidence of acute spinal cord infarction in population-based studies.</p><p><strong>Objectives: </strong>To determine the incidence of acute spinal cord infarction using a population-based design.</p><p><strong>Methods: </strong>Medical records and neuroimaging data of all patients with acute spinal cord infarction from Stearns and Benton Counties, Minnesota, between January 1, 2010 and May 31, 2014 were reviewed. Patients with a first-time diagnosis of spinal cord infarction were categorized as primary or secondary depending upon underlying etiology identified. We calculated the incidences of primary and secondary spinal cord infarction adjusted for age and sex based on the 2010 US census (189,093 resident populations).</p><p><strong>Results: </strong>The age- and sex-adjusted incidence of spinal cord infarction was 3.1 [95% confidence interval (CI) 1.6-7.2] per100,000 person-years. The age- and sex-adjusted incidence of primary and secondary spinal cord infarction was 1.5 [95% CI 0.6-3.6] and 1.6 [95% CI 0.6-3.6] per 100,000 person-years, respectively. The age-adjusted incidences among men and women were 1.5 [95%CI 0.6-3.7] and 4.6 [95% CI 2.2-8.7] per 100,000 person-years, respectively. No case fatality was observed at one month.</p><p><strong>Conclusion: </strong>We provide incidence rates for acute spinal cord infarction to assist in future studies and resource allocation.</p>","PeriodicalId":88555,"journal":{"name":"Journal of vascular and interventional neurology","volume":"9 4","pages":"44-48"},"PeriodicalIF":0.0,"publicationDate":"2017-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5501128/pdf/jvin-9-4-8.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35164120","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Staged Arterial and Venous Embolizations in Treatment of Type IV Intraosseous Dural Arteriovenous Fistula. 分阶段动静脉栓塞治疗IV型硬膜内动静脉瘘。
Aleksandra V Betcher, Andrew W Schnure, Paul H Janda, Rajneesh Agrawal, Amandeep Dhillon

Objective: This is a case report of an adult male with complex type IV intraosseous DAVF causing severe venous hypertension and bony destruction, presenting with severe hemotympanum, and a novel way of staged arterial and venous embolizations to treat the emergent symptoms.

Methods: First and second stages were direct selective arterial embolizations using Onyx liquid agent. Goal was to reduce flow into the fistula by embolizing the feeder branch and distal penetration of the nidus with Onyx. The third stage was performed through the venous route: the transverse sinus and the sigmoid sinus were embolized using Penumbra Ruby coils and Onyx, two microcatheters were used and two large coils were placed simultaneously to form a stable coil mass, and the entire sinus was embolized using Coils and Onyx.

Results: Patient's venous hypertension and degree of hydrocephalus had significantly decreased after the procedure. He was able to return to work, but was instructed to avoid heavy lifting and placing anything in and around his right ear.

Conclusions: Multiple step arterial and venous embolization procedures were successful in decreasing the frequency of hemotympanum, degree of hydrocephalus, and improving quality of life of this patient.

目的:报告1例成年男性复杂IV型骨内DAVF,并发严重静脉高压及骨破坏,表现为严重的鼓室出血,提出了分阶段动、静脉栓塞治疗突发性症状的新方法。方法:第一、二期采用玛瑙液直接选择性动脉栓塞。目的是通过用玛瑙栓塞给药分支和远端穿透病灶来减少流入瘘管的流量。第三阶段通过静脉途径:使用半影Ruby线圈和Onyx栓塞横窦和乙状窦,使用两根微导管,同时放置两个大线圈,形成稳定的线圈团,使用线圈和Onyx栓塞整个窦。结果:术后患者静脉高压及脑积水程度明显降低。他能够重返工作岗位,但被告知不要搬运重物,也不要在右耳内或周围放置任何东西。结论:多步骤动、静脉栓塞治疗可有效降低鼓室积血的发生频率,降低脑积水程度,提高患者的生活质量。
{"title":"Staged Arterial and Venous Embolizations in Treatment of Type IV Intraosseous Dural Arteriovenous Fistula.","authors":"Aleksandra V Betcher,&nbsp;Andrew W Schnure,&nbsp;Paul H Janda,&nbsp;Rajneesh Agrawal,&nbsp;Amandeep Dhillon","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>This is a case report of an adult male with complex type IV intraosseous DAVF causing severe venous hypertension and bony destruction, presenting with severe hemotympanum, and a novel way of staged arterial and venous embolizations to treat the emergent symptoms.</p><p><strong>Methods: </strong>First and second stages were direct selective arterial embolizations using Onyx liquid agent. Goal was to reduce flow into the fistula by embolizing the feeder branch and distal penetration of the nidus with Onyx. The third stage was performed through the venous route: the transverse sinus and the sigmoid sinus were embolized using Penumbra Ruby coils and Onyx, two microcatheters were used and two large coils were placed simultaneously to form a stable coil mass, and the entire sinus was embolized using Coils and Onyx.</p><p><strong>Results: </strong>Patient's venous hypertension and degree of hydrocephalus had significantly decreased after the procedure. He was able to return to work, but was instructed to avoid heavy lifting and placing anything in and around his right ear.</p><p><strong>Conclusions: </strong>Multiple step arterial and venous embolization procedures were successful in decreasing the frequency of hemotympanum, degree of hydrocephalus, and improving quality of life of this patient.</p>","PeriodicalId":88555,"journal":{"name":"Journal of vascular and interventional neurology","volume":"9 4","pages":"17-21"},"PeriodicalIF":0.0,"publicationDate":"2017-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5501124/pdf/jvin-9-4-4.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35163732","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Patient Preference for Transradial Access over Transfemoral Access for Cerebrovascular Procedures. 经桡动脉入路比经股动脉入路进行脑血管手术的患者偏好。
Sudhakar R Satti, Ansar Z Vance, Sohil N Golwala, Tim Eden

Purpose: Shared decision-making, when physicians and patients collaborate and agree on health care decisions, is a key tenant of patient-centered care. Choice of access site for neurovascular procedures is rarely a shared decision point between physicians and patients. We present our initial evaluation of patient preference for radial over femoral access for cerebrovascular procedures.

Materials and methods: IRB approved single-center, prospective, and consecutive survey of all patients undergoing transradial access for cerebrovascular imaging and intervention. Primary inclusion criteria were patients who had previously undergone a transfemoral access procedure and chose to have their second procedure via a transradial approach. All patients underwent pre-procedural neurologic and extremity exams (including Barbeau tests for radial access suitability prior to radial access), post-procedural neurological evaluation and radial access assessment post-procedure, and complete neurological and radial access-site evaluation in the neurointerventional outpatient clinic 1-2 week post-procedure.

Results: Twenty five consecutive patients who underwent radial access cerebrovascular procedures after previous femoral access cerebrovascular procedures (16 diagnostic angiograms and 9 interventional procedures) were included. No major complications (including hematomas, infection, or delayed radial artery occlusion) were encountered during the immediate post-procedurral period or on outpatient follow-up (average 8 days). On immediate post-procedural examination, 16% had mild bruising and 24% had mild pain at the radial access site. Of the 25 patients included in this study, 24 strongly preferred radial access over femoral access and reported that, if they needed another procedure, they would prefer radial access.

Conclusion: There was nearly unanimous patient preference for radial over femoral access for cerebrovascular procedures in this single-center prospective analysis. There were no major complications and no incidences of delayed radial occlusion. In the current age of value-based and patient-centered medicine, the radial approach should be considered for nearly all neurovascular procedures.

目的:共同决策是指医生和患者就医疗决策进行合作并达成一致,是以患者为中心的医疗服务的重要原则。选择神经血管手术的入路部位很少成为医生和患者共同决策的要点。我们将对患者在脑血管手术中选择桡动脉入路而非股动脉入路的偏好进行初步评估:经 IRB 批准的单中心、前瞻性和连续性调查,调查对象为所有接受经桡动脉入路脑血管成像和介入治疗的患者。主要纳入标准是曾接受过经腿入路手术并选择经桡动脉入路进行第二次手术的患者。所有患者均接受了术前神经系统和四肢检查(包括桡动脉入路前的桡动脉入路适宜性Barbeau测试)、术后神经系统评估和术后桡动脉入路评估,并在术后1-2周在神经介入门诊接受了完整的神经系统和桡动脉入路部位评估:共纳入了 25 名曾接受过股动脉入路脑血管手术(16 例诊断性血管造影和 9 例介入手术)后又接受了桡动脉入路脑血管手术的连续患者。术后即刻或门诊随访期间(平均 8 天)未出现重大并发症(包括血肿、感染或延迟桡动脉闭塞)。术后即刻检查时,16% 的患者有轻微瘀伤,24% 的患者桡动脉入路部位有轻微疼痛。在参与本研究的25名患者中,有24人强烈倾向于桡动脉入路而非股动脉入路,并表示如果需要再次手术,他们会选择桡动脉入路:结论:在这项单中心前瞻性分析中,脑血管手术患者几乎一致选择桡动脉入路而非股动脉入路。没有出现重大并发症,也没有发生延迟桡动脉闭塞。在当前以价值为基础、以患者为中心的医疗时代,几乎所有的神经血管手术都应考虑采用桡动脉入路。
{"title":"Patient Preference for Transradial Access over Transfemoral Access for Cerebrovascular Procedures.","authors":"Sudhakar R Satti, Ansar Z Vance, Sohil N Golwala, Tim Eden","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Purpose: </strong>Shared decision-making, when physicians and patients collaborate and agree on health care decisions, is a key tenant of patient-centered care. Choice of access site for neurovascular procedures is rarely a shared decision point between physicians and patients. We present our initial evaluation of patient preference for radial over femoral access for cerebrovascular procedures.</p><p><strong>Materials and methods: </strong>IRB approved single-center, prospective, and consecutive survey of all patients undergoing transradial access for cerebrovascular imaging and intervention. Primary inclusion criteria were patients who had previously undergone a transfemoral access procedure and chose to have their second procedure via a transradial approach. All patients underwent pre-procedural neurologic and extremity exams (including Barbeau tests for radial access suitability prior to radial access), post-procedural neurological evaluation and radial access assessment post-procedure, and complete neurological and radial access-site evaluation in the neurointerventional outpatient clinic 1-2 week post-procedure.</p><p><strong>Results: </strong>Twenty five consecutive patients who underwent radial access cerebrovascular procedures after previous femoral access cerebrovascular procedures (16 diagnostic angiograms and 9 interventional procedures) were included. No major complications (including hematomas, infection, or delayed radial artery occlusion) were encountered during the immediate post-procedurral period or on outpatient follow-up (average 8 days). On immediate post-procedural examination, 16% had mild bruising and 24% had mild pain at the radial access site. Of the 25 patients included in this study, 24 strongly preferred radial access over femoral access and reported that, if they needed another procedure, they would prefer radial access.</p><p><strong>Conclusion: </strong>There was nearly unanimous patient preference for radial over femoral access for cerebrovascular procedures in this single-center prospective analysis. There were no major complications and no incidences of delayed radial occlusion. In the current age of value-based and patient-centered medicine, the radial approach should be considered for nearly all neurovascular procedures.</p>","PeriodicalId":88555,"journal":{"name":"Journal of vascular and interventional neurology","volume":"9 4","pages":"1-5"},"PeriodicalIF":0.0,"publicationDate":"2017-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5501120/pdf/jvin-9-4-1.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35163729","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cerebral Infarction as a Rare Complication of Wasp Sting. 蜂蜇伤致脑梗死的罕见并发症。
Payam Moein, Ramin Zand
{"title":"Cerebral Infarction as a Rare Complication of Wasp Sting.","authors":"Payam Moein,&nbsp;Ramin Zand","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":88555,"journal":{"name":"Journal of vascular and interventional neurology","volume":"9 4","pages":"13-16"},"PeriodicalIF":0.0,"publicationDate":"2017-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5501123/pdf/jvin-9-4-3.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35163731","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inpatient versus Outpatient Management of TIA or Minor Stroke: Clinical Outcome. TIA或轻微卒中的住院与门诊治疗:临床结果。
Shahram Majidi, Christopher R Leon Guerrero, Kathleen M Burger, John F Rothrock

Background: The management of patients with acute transient ischemic attack (TIA) or minor stroke is highly variable. Whether hospitalization of such patients significantly improves short-term clinical outcome is unknown. We assessed the short-term clinical outcome associated with inpatient versus outpatient management of patients with TIA or minor stroke.

Methods: We evaluated a consecutive series of patients with acute TIA or minor ischemic stroke (NIH Stroke Scale score ≤ 3) presenting to a single emergency department (ED). We randomized patients to either hospital-based or outpatient-based management. All patients underwent interview and examination 7-10 days following the index event.

Results: This study included 100 patients, 41 with TIA and 59 with minor stroke. Nineteen (46%) of the TIA patients and 29 (49%) of the minor stroke patients randomized to hospital management, and the remaining 22 TIA patients and 30 minor stroke patients randomized to outpatient-based management. In the patients with a minor stroke, neurologic worsening occurred in 6 out of 29 (21%) in the inpatient arm compared with 3 out of 30 (10%) in the outpatient arm (p = 0.3). In none of these cases was acute interventional therapy or need for urgent admission considered medically appropriate. In the patients with a TIA, recurrence of a TIA occurred in 2 out of 19 (11%) in the inpatient arm compared with 2 out of 22 (9%) in the outpatient arm (p = 1). None of the patients with a TIA randomized to the inpatient arm experienced a stroke compared with 1 out of 22 in the outpatient arm (p = 1). There were no deaths in either group.

Conclusion: Routine hospitalization of all patients with TIA or minor ischemic stroke may not positively affect short-term clinical outcome.

背景:急性短暂性脑缺血发作(TIA)或轻微脑卒中患者的处理是高度可变的。这些患者的住院治疗是否能显著改善短期临床结果尚不清楚。我们评估了TIA或轻微卒中患者住院与门诊管理相关的短期临床结果。方法:我们评估了在单一急诊科(ED)就诊的连续一系列急性TIA或轻微缺血性卒中(NIH卒中量表评分≤3)患者。我们将患者随机分为医院管理和门诊管理两组。所有患者在指数事件发生后7-10天接受访谈和检查。结果:本研究纳入100例患者,其中TIA 41例,轻度脑卒中59例。19例TIA患者(46%)和29例轻度卒中患者(49%)随机分配到医院管理,其余22例TIA患者和30例轻度卒中患者随机分配到门诊管理。在轻度中风患者中,住院组29人中有6人(21%)出现神经系统恶化,而门诊组30人中有3人(10%)出现神经系统恶化(p = 0.3)。在这些病例中,没有一个是急性介入治疗或需要紧急入院认为医学上适当的。在TIA患者中,住院组19例中有2例(11%)复发,而门诊组22例中有2例(9%)复发(p = 1)。随机分配到住院组的TIA患者均未发生卒中,而门诊组22例中有1例(p = 1)。两组均无死亡病例。结论:所有TIA或轻度缺血性脑卒中患者的常规住院治疗可能不会对短期临床预后产生积极影响。
{"title":"Inpatient versus Outpatient Management of TIA or Minor Stroke: Clinical Outcome.","authors":"Shahram Majidi,&nbsp;Christopher R Leon Guerrero,&nbsp;Kathleen M Burger,&nbsp;John F Rothrock","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>The management of patients with acute transient ischemic attack (TIA) or minor stroke is highly variable. Whether hospitalization of such patients significantly improves short-term clinical outcome is unknown. We assessed the short-term clinical outcome associated with inpatient versus outpatient management of patients with TIA or minor stroke.</p><p><strong>Methods: </strong>We evaluated a consecutive series of patients with acute TIA or minor ischemic stroke (NIH Stroke Scale score ≤ 3) presenting to a single emergency department (ED). We randomized patients to either hospital-based or outpatient-based management. All patients underwent interview and examination 7-10 days following the index event.</p><p><strong>Results: </strong>This study included 100 patients, 41 with TIA and 59 with minor stroke. Nineteen (46%) of the TIA patients and 29 (49%) of the minor stroke patients randomized to hospital management, and the remaining 22 TIA patients and 30 minor stroke patients randomized to outpatient-based management. In the patients with a minor stroke, neurologic worsening occurred in 6 out of 29 (21%) in the inpatient arm compared with 3 out of 30 (10%) in the outpatient arm (<i>p</i> = 0.3). In none of these cases was acute interventional therapy or need for urgent admission considered medically appropriate. In the patients with a TIA, recurrence of a TIA occurred in 2 out of 19 (11%) in the inpatient arm compared with 2 out of 22 (9%) in the outpatient arm (<i>p</i> = 1). None of the patients with a TIA randomized to the inpatient arm experienced a stroke compared with 1 out of 22 in the outpatient arm (<i>p</i> = 1). There were no deaths in either group.</p><p><strong>Conclusion: </strong>Routine hospitalization of all patients with TIA or minor ischemic stroke may not positively affect short-term clinical outcome.</p>","PeriodicalId":88555,"journal":{"name":"Journal of vascular and interventional neurology","volume":"9 4","pages":"49-53"},"PeriodicalIF":0.0,"publicationDate":"2017-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5501129/pdf/jvin-9-4-9.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35164121","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bilateral Ophthalmic Artery Dissecting Aneurysms Presenting with Recurrent Epistaxis. 双侧眼动脉夹层动脉瘤表现为复发性鼻出血。
Ali Al Balushi, Jacob Kitchener, Randall C Edgell

We present a rare case of bilateral expanding traumatic pseudoaneurysms of the ophthalmic arteries, due to a gunshot. The aneurysms presented with epistaxis. After a failure of conservative management, coil embolization of the aneurysms resulted in complete occlusion, with preservation of flow in the parent vessels.

我们提出一个罕见的病例扩大双侧创伤性假性动脉瘤的眼动脉,由于枪击。动脉瘤表现为鼻出血。保守治疗失败后,动脉瘤线圈栓塞导致完全闭塞,保留了母血管的血流。
{"title":"Bilateral Ophthalmic Artery Dissecting Aneurysms Presenting with Recurrent Epistaxis.","authors":"Ali Al Balushi,&nbsp;Jacob Kitchener,&nbsp;Randall C Edgell","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>We present a rare case of bilateral expanding traumatic pseudoaneurysms of the ophthalmic arteries, due to a gunshot. The aneurysms presented with epistaxis. After a failure of conservative management, coil embolization of the aneurysms resulted in complete occlusion, with preservation of flow in the parent vessels.</p>","PeriodicalId":88555,"journal":{"name":"Journal of vascular and interventional neurology","volume":"9 3","pages":"14-16"},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5317286/pdf/jvin-9-3-3.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34769255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Spanish Version of the National Institutes of Health Stroke Scale: Awareness and Use in United States. A Survey Study. 西班牙文版美国国立卫生研究院卒中量表:美国的认知和使用情况。调查研究。
Enrique Villalobos, Scott R Barnes, Ihtesham A Qureshi, Salvador Cruz-Flores, Alberto Maud, Gustavo J Rodriguez

Objective: To investigate the awareness and the use of Spanish version of National Institutes of Health Stroke Scale (NIHSS) throughout the United States (US) by regions using a web-based survey.

Methods: A survey targeting physicians from two specialties that regularly manage acute stroke patients was conducted from February to August of 2015. Academic centers from the Accreditation Council for Graduate Medical Education online directory belonging to emergency medicine (EM) and neurology residency programs were identified. The questionnaire was composed of ten questions separated into three different groups. The responses received from the programs were separated by specialty and grouped into different regions in the US for comparison.

Results: Out of 230 residency-invited programs, we received a total of 73 responses, 35 from EM and 26 responses from neurology residency programs. In addition, 12 respondents were categorized as unknown recipients. The South region had the highest response rate with 30.3%. There was no significant difference in the responses by region if Puerto Rico was not analyzed. Interviewees reported a substantial percentage of Spanish-speaking patients reported across the regions and more than 75% of the programs report lack of knowledge of the Spanish version of the NIHSS and/or the use of it.

Conclusion: There may be a need to increase awareness and to promote the use of the Spanish version of the NIHSS. Spanish-speaking population in the US may be inaccurately assessed for acute stroke and could impact the outcomes. Larger population studies should be conducted to confirm our findings.

Author contributions: Dr. Villalobos and Dr. Barnes are involved in formulating the study concept and design; Dr. Rodriguez and Dr. Maud are involved in manuscript writing; Dr. Qureshi is involved in statistical analysis of the data; Dr. Cruz-Flores is involved in critical revision of the manuscript.

Disclosures: Dr. Villalobos reports no disclosure; Dr. Barnes reports no disclosure; Dr. Qureshi reports no disclosure; Dr. Cruz-Flores reports no disclosure; Dr. Maud reports no disclosure; Dr. Rodriguez reports no disclosure.

目的通过网络调查了解美国各地区对西班牙文版美国国立卫生研究院卒中量表(NIHSS)的认知和使用情况:方法:2015 年 2 月至 8 月,针对定期管理急性卒中患者的两个专科的医生进行了一项调查。从毕业后医学教育认证委员会(Accreditation Council for Graduate Medical Education)的在线目录中确定了属于急诊医学(EM)和神经病学住院医师培训项目的学术中心。问卷由十个问题组成,分为三个不同的组别。从项目中收到的答复按专业分类,并按美国不同地区进行分组,以便比较:在 230 个受邀的住院医师培训项目中,我们共收到 73 份回复,其中 35 份来自于电磁学,26 份来自于神经学住院医师培训项目。此外,还有 12 名受访者被归类为未知受访者。南部地区的回复率最高,为 30.3%。如果不对波多黎各进行分析,则各地区的回复没有明显差异。受访者报告称,各地区讲西班牙语的患者比例都很高,超过 75% 的项目报告称对西班牙语版 NIHSS 和/或其使用缺乏了解:结论:可能需要提高对西班牙语版 NIHSS 的认识并推广其使用。美国讲西班牙语的人群对急性卒中的评估可能不准确,并可能影响预后。应开展更大规模的人群研究来证实我们的发现:Villalobos 博士和 Barnes 博士参与了研究概念和设计的制定;Rodriguez 博士和 Maud 博士参与了手稿的撰写;Qureshi 博士参与了数据统计分析;Cruz-Flores 博士参与了手稿的重要修订:Villalobos 博士未披露任何信息;Barnes 博士未披露任何信息;Qureshi 博士未披露任何信息;Cruz-Flores 博士未披露任何信息;Maud 博士未披露任何信息;Rodriguez 博士未披露任何信息。
{"title":"Spanish Version of the National Institutes of Health Stroke Scale: Awareness and Use in United States. A Survey Study.","authors":"Enrique Villalobos, Scott R Barnes, Ihtesham A Qureshi, Salvador Cruz-Flores, Alberto Maud, Gustavo J Rodriguez","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the awareness and the use of Spanish version of National Institutes of Health Stroke Scale (NIHSS) throughout the United States (US) by regions using a web-based survey.</p><p><strong>Methods: </strong>A survey targeting physicians from two specialties that regularly manage acute stroke patients was conducted from February to August of 2015. Academic centers from the Accreditation Council for Graduate Medical Education online directory belonging to emergency medicine (EM) and neurology residency programs were identified. The questionnaire was composed of ten questions separated into three different groups. The responses received from the programs were separated by specialty and grouped into different regions in the US for comparison.</p><p><strong>Results: </strong>Out of 230 residency-invited programs, we received a total of 73 responses, 35 from EM and 26 responses from neurology residency programs. In addition, 12 respondents were categorized as unknown recipients. The South region had the highest response rate with 30.3%. There was no significant difference in the responses by region if Puerto Rico was not analyzed. Interviewees reported a substantial percentage of Spanish-speaking patients reported across the regions and more than 75% of the programs report lack of knowledge of the Spanish version of the NIHSS and/or the use of it.</p><p><strong>Conclusion: </strong>There may be a need to increase awareness and to promote the use of the Spanish version of the NIHSS. Spanish-speaking population in the US may be inaccurately assessed for acute stroke and could impact the outcomes. Larger population studies should be conducted to confirm our findings.</p><p><strong>Author contributions: </strong>Dr. Villalobos and Dr. Barnes are involved in formulating the study concept and design; Dr. Rodriguez and Dr. Maud are involved in manuscript writing; Dr. Qureshi is involved in statistical analysis of the data; Dr. Cruz-Flores is involved in critical revision of the manuscript.</p><p><strong>Disclosures: </strong>Dr. Villalobos reports no disclosure; Dr. Barnes reports no disclosure; Dr. Qureshi reports no disclosure; Dr. Cruz-Flores reports no disclosure; Dr. Maud reports no disclosure; Dr. Rodriguez reports no disclosure.</p>","PeriodicalId":88555,"journal":{"name":"Journal of vascular and interventional neurology","volume":"9 3","pages":"1-6"},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5317283/pdf/jvin-9-3-1.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34769253","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mycotic Intracranial Aneurysm Secondary to Left Ventricular Assist Device Infection. 继发于左心室辅助装置感染的真菌性颅内动脉瘤。
Juan M Remirez, Yasmin Sabet, Marshall Baca, Alberto Maud, Salvador Cruz-Flores, Gustavo J Rodriguez, Debabrata Mukherjee, Aamer Abbas

Background: Mycotic aneurysms are a complication of infective endocarditis. Infection of left ventricular assist devices (LVADs) may lead to bacteremia and fever causing complications similar to those seen in patients with prosthetic valve endocarditis. Intracranial mycotic aneurysms are rare, and their presence is signaled by the development of subarachnoid hemorrhage in the setting of bacteremia and aneurysms located distal to the circle of Willis.

Case presentation: We present the case of a patient with a LVAD presenting with headache who is found to have an intracranial mycotic aneurysm through computed tomography angiography of the head. The patient was successfully treated with endovascular intervention.

Conclusion: In patients with LVADs, mycotic aneurysms have been reported, however not intracranially. To the best of our knowledge, this is the first intracranial mycotic aneurysm secondary to LVAD infection that was successfully treated with endovascular repair. Intracranial mycotic aneurysms associated with LVADs are a rare phenomenon. The diagnosis of mycotic aneurysms requires a high index of suspicion in patients who present with bacteremia with or without headache and other neurological symptoms.

Disclosure: None.

背景:真菌性动脉瘤是感染性心内膜炎的并发症。左心室辅助装置(lvad)感染可能导致菌血症和发热,引起类似于人工瓣膜心内膜炎患者的并发症。颅内真菌性动脉瘤是罕见的,其存在的信号是在菌血症和位于Willis环远端动脉瘤的背景下发生蛛网膜下腔出血。病例介绍:我们提出的情况下,患者与左心室辅助装置提出头痛谁是发现有颅内真菌性动脉瘤通过计算机断层扫描血管摄影的头部。患者经血管内介入治疗成功。结论:在lvad患者中,有真菌性动脉瘤的报道,但没有颅内。据我们所知,这是第一例通过血管内修复成功治疗左心室辅助器感染继发的颅内真菌性动脉瘤。颅内真菌性动脉瘤与左心室辅助功能相关是一种罕见的现象。真菌性动脉瘤的诊断需要对伴有或不伴有头痛和其他神经系统症状的菌血症患者进行高度的怀疑。披露:没有。
{"title":"Mycotic Intracranial Aneurysm Secondary to Left Ventricular Assist Device Infection.","authors":"Juan M Remirez,&nbsp;Yasmin Sabet,&nbsp;Marshall Baca,&nbsp;Alberto Maud,&nbsp;Salvador Cruz-Flores,&nbsp;Gustavo J Rodriguez,&nbsp;Debabrata Mukherjee,&nbsp;Aamer Abbas","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Mycotic aneurysms are a complication of infective endocarditis. Infection of left ventricular assist devices (LVADs) may lead to bacteremia and fever causing complications similar to those seen in patients with prosthetic valve endocarditis. Intracranial mycotic aneurysms are rare, and their presence is signaled by the development of subarachnoid hemorrhage in the setting of bacteremia and aneurysms located distal to the circle of Willis.</p><p><strong>Case presentation: </strong>We present the case of a patient with a LVAD presenting with headache who is found to have an intracranial mycotic aneurysm through computed tomography angiography of the head. The patient was successfully treated with endovascular intervention.</p><p><strong>Conclusion: </strong>In patients with LVADs, mycotic aneurysms have been reported, however not intracranially. To the best of our knowledge, this is the first intracranial mycotic aneurysm secondary to LVAD infection that was successfully treated with endovascular repair. Intracranial mycotic aneurysms associated with LVADs are a rare phenomenon. The diagnosis of mycotic aneurysms requires a high index of suspicion in patients who present with bacteremia with or without headache and other neurological symptoms.</p><p><strong>Disclosure: </strong>None.</p>","PeriodicalId":88555,"journal":{"name":"Journal of vascular and interventional neurology","volume":"9 3","pages":"23-25"},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5317288/pdf/jvin-9-3-5.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34769182","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Safety and Efficacy of Intensified Antiplatelet Therapy in Patients Undergoing Neuroendovascular Procedures. 神经血管内手术患者强化抗血小板治疗的安全性和有效性。
Senka Runjaic, Jerah D Nordeen, Matthew W Soto-Arenall, Gretchen S Johns, David Miller, Benjamin Brown, William D Freeman

Introduction: The purpose of this study was to evaluate safety and efficacy of intensified antiplatelet therapy guided by VerifyNow assay P2Y12 reaction unit (PRU) reported values in patients undergoing neuroendovascular procedures.

Methods: An observational, retrospective review was conducted at a single academic tertiary referral center and comprehensive stroke center from December 1, 2012, to August 31, 2014. The primary objective was to determine the prevalence of thromboembolic complications stratified by preprocedural PRU values. Secondary outcomes were assessed by investigating whether the goal PRU value of 190 or less is sufficient to reduce thromboembolic complications on the day of the procedure, and 30- and 90-day postprocedure.

Results: There was no statistically significant difference in the overall rate of complications in the two groups (two events in the group with preprocedural PRU values of 190 or more versus seven events in the group with preprocedural PRU values of less than 190, p = 0.668). Furthermore, the rates of thromboembolic events by 90 days were not significantly different in the two groups (one event in the group with preprocedural PRU ≥ 190 versus four events in patients with preprocedural PRU < 190, p = 1). Similarly, there was no statistically significant difference in the rate of hemorrhagic events in the two groups by 90-day postprocedure (one versus three events, p = 0.558).

Conclusion: The observed rate of thromboembolic and hemorrhagic complications in patients with preprocedural PRU values of less than 190 was not significantly different from the rate observed in patients with preprocedural PRU values of greater than 190. Sources of funding: No external funding used.

本研究的目的是评估由VerifyNow测定P2Y12反应单元(PRU)报告值指导的强化抗血小板治疗在接受神经血管内手术患者中的安全性和有效性。方法:对2012年12月1日至2014年8月31日在某单一学术三级转诊中心和综合性脑卒中中心进行观察性回顾性分析。主要目的是通过术前PRU值分层确定血栓栓塞并发症的发生率。次要结果通过调查目标PRU值190或更低是否足以减少手术当天以及手术后30天和90天的血栓栓塞并发症来评估。结果:两组总并发症发生率比较差异无统计学意义(术前PRU为190及以上组2例,术前PRU小于190组7例,p = 0.668)。此外,两组患者术后90天的血栓栓塞事件发生率无显著差异(术前PRU≥190组1例,而术前PRU < 190组4例,p = 1)。同样,两组患者术后90天的出血事件发生率无统计学差异(1例对3例,p = 0.558)。结论:术前PRU值小于190的患者的血栓栓塞和出血性并发症发生率与术前PRU值大于190的患者的发生率无显著差异。资金来源:未使用外部资金。
{"title":"Safety and Efficacy of Intensified Antiplatelet Therapy in Patients Undergoing Neuroendovascular Procedures.","authors":"Senka Runjaic,&nbsp;Jerah D Nordeen,&nbsp;Matthew W Soto-Arenall,&nbsp;Gretchen S Johns,&nbsp;David Miller,&nbsp;Benjamin Brown,&nbsp;William D Freeman","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>The purpose of this study was to evaluate safety and efficacy of intensified antiplatelet therapy guided by VerifyNow assay P2Y<sub>12</sub> reaction unit (PRU) reported values in patients undergoing neuroendovascular procedures.</p><p><strong>Methods: </strong>An observational, retrospective review was conducted at a single academic tertiary referral center and comprehensive stroke center from December 1, 2012, to August 31, 2014. The primary objective was to determine the prevalence of thromboembolic complications stratified by preprocedural PRU values. Secondary outcomes were assessed by investigating whether the goal PRU value of 190 or less is sufficient to reduce thromboembolic complications on the day of the procedure, and 30- and 90-day postprocedure.</p><p><strong>Results: </strong>There was no statistically significant difference in the overall rate of complications in the two groups (two events in the group with preprocedural PRU values of 190 or more versus seven events in the group with preprocedural PRU values of less than 190, <i>p</i> = 0.668). Furthermore, the rates of thromboembolic events by 90 days were not significantly different in the two groups (one event in the group with preprocedural PRU ≥ 190 versus four events in patients with preprocedural PRU < 190, <i>p</i> = 1). Similarly, there was no statistically significant difference in the rate of hemorrhagic events in the two groups by 90-day postprocedure (one versus three events, <i>p</i> = 0.558).</p><p><strong>Conclusion: </strong>The observed rate of thromboembolic and hemorrhagic complications in patients with preprocedural PRU values of less than 190 was not significantly different from the rate observed in patients with preprocedural PRU values of greater than 190. Sources of funding: No external funding used.</p>","PeriodicalId":88555,"journal":{"name":"Journal of vascular and interventional neurology","volume":"9 3","pages":"51-56"},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5317284/pdf/jvin-9-3-10.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34769187","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of vascular and interventional neurology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1